期刊文献+

卵巢恶性肿瘤11例治疗分析

下载PDF
导出
摘要 目的总结我院卵巢恶性肿瘤的治疗情况。方法对我院1993年 ̄2004年12年以来收治的11例卵巢恶性肿瘤进行回顾分析。结果患者年龄最小15岁,最大64岁,均经手术病检确诊。按组织学分类:黏液性囊腺癌1例,浆液性囊腺癌1例,颗粒细胞瘤1例,无性细胞瘤1例,胚胎癌1例,内胚窦瘤2例,未成熟畸胎瘤2例,转移性囊腺癌2例。临床分期Ⅰ期8例,Ⅱ期2例,Ⅲ期1例。治疗为手术加化疗。5例行腹腔化疗,5例静脉给药化疗,另1例术后拒绝化疗。接受化疗10例现存活9例,生存最长已12年,1例Ⅲ期转移性癌症患者于术后8个月死亡。结论卵巢恶性肿瘤早期诊断是达到良好疗效的关键;手术加化疗是卵巢恶性肿瘤治疗的主要手段;随访制度的坚持是总结卵巢恶性肿瘤治疗经验不可缺少的环节。
机构地区 绥德县人民医院
出处 《基层医学论坛》 2006年第1期35-35,共1页 The Medical Forum
  • 相关文献

参考文献4

二级参考文献19

  • 1Chen ZC, Tanemura M, Galili U. Synthesis of alpha-gal epitopes (Galalpha1-3Galbeta1-4GlcNAc-R) on human tumor cells by recombinant alpha1,3galactosyltransferase produced in Pichia pastoris.Glycobiology,2001, 11:577-586.
  • 2Takashima I, Yamagushi Y, Yorishima T, et al. Immunological properties of tumor cells genetically modified to secrete interleukin-2.Anticancer Res,1999, 19:5299-5306.
  • 3Hwu P, Freedman RS. The immunotherapy of patients with ovarian cancer.J Immunother,2002, 25:189-201.
  • 4Disis ML, Gooley TA, Rinn K, et al. Generation of T-cell immunity to the HER-2/neu protein after active immunization with HER-2/neu peptide-based vaccines.J Clin Oncol,2002, 20:2624-2632.
  • 5Baxevanis CN, Gritzapis AD, Tsitsilonis OE, et al. HER-2/neu-derived peptide epitopes are also recognized by cytotoxic CD3(+)CD56(+) (natural killer T) lymphocytes. Int J Cancer,2002, 98:864-872.
  • 6Hsu CT, Ting CY, Ting CJ, et al. Vaccination against gonadotropin-releasing hormone (GnRH) using toxin receptor-binding domain-conjugated GnRH repeats.Cancer Res,2000, 60:3701-3705.
  • 7Peoples GE, Anderson BW, Lee TV, et al. Vaccine implications of folate binding protein, a novel cytotoxic T lymphocyte-recognized antigen system in epithelial cancers.Clin Cancer Res, 1999, 5:4214-4223.
  • 8Neglia F, Orengo AM, Cilli M, et al. DNA vaccination against the ovarian carcinoma-associated antigen folate receptor alpha (FRalpha) induces cytotoxic T lymphocyte and antibody responses in mice.Cancer Gene Ther,1999,6:349-357.
  • 9Sabbatini PJ, Kudryashov V, Ragupathi G, et al. Immunization of ovarian cancer patients with a synthetic Lewis(y)-protein conjugate vaccine: a phase 1 trial.Int J Cancer,2000, 87:79-85.
  • 10Sandmaier BM, Oparin DV, Holmberg LA, et al. Evidence of a cellular immune response against sialyl-Tn in breast and ovarian cancer patients after high-dose chemotherapy, stem cell rescue, and immunization with Theratope STn-KLH cancer vaccine. J Immunothe

共引文献135

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部